<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03479944</url>
  </required_header>
  <id_info>
    <org_study_id>CTB258-P001</org_study_id>
    <nct_id>NCT03479944</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of FLACS With Combination of LenSx® and Centurion®</brief_title>
  <official_title>Clinical Evaluation of FLACS (Femtosecond Laser Assisted Cataract Surgery) With Combination of LenSx® and Centurion®</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate cumulative dissipated energy (CDE), endothelial cell
      loss, and average torsional amplitude with combination of LenSx® and Centurion® compared to
      conventional cataract surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will attend 7 scheduled visits: 1 pre-operative, 1 operative, and 5 post-operative.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative Dissipated Energy (CDE)</measure>
    <time_frame>Surgery (Day 0)</time_frame>
    <description>CDE (the energy dissipated at the incision point during the removal of cataractous lens) will be measured.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent change of corneal endothelial cell density (ECD)</measure>
    <time_frame>Day 150-210 post-surgery</time_frame>
    <description>Specular microscopy will be performed and endothelial cell density will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average torsional amplitude</measure>
    <time_frame>Surgery (Day 0)</time_frame>
    <description>Torsional amplitude will be recorded by Centurion® and measured as a percentage.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>FLACS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FLACS in 1 eye, with manual conventional surgery in the fellow eye, as randomized</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Manual conventional surgery in 1 eye, with FLACS in the fellow eye, as randomized</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FLACS</intervention_name>
    <description>Femtosecond laser assisted cataract surgery consisting of LenSx® and Centurion® combination</description>
    <arm_group_label>FLACS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Manual conventional surgery</intervention_name>
    <description>Removal of cataractous lens by phacoemulsification</description>
    <arm_group_label>Conventional</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CENTURION® Vision System</intervention_name>
    <description>Phacoemulsification aspiration platform for use during cataract surgery</description>
    <arm_group_label>FLACS</arm_group_label>
    <arm_group_label>Conventional</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LenSx®</intervention_name>
    <description>Femtosecond laser system used for continuous curvilinear capsulorhexis (CCC) and lens fragmentation during cataract surgery</description>
    <arm_group_label>FLACS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cataracts (Grade 2-4 of Emery-Little Classification) with planned cataract removal by
             phacoemulsification in both eyes;

          -  Able to comprehend and willing to sign informed consent and complete all required
             postoperative follow-up procedures;

          -  Calculated lens power within the available range;

          -  Other protocol-specified inclusion criteria may apply.

        Exclusion Criteria:

          -  Any pathology that could reduce visual potential;

          -  Hypotony or the presence of a corneal implant;

          -  Residual, recurrent, active ocular or eyelid disease;

          -  Poorly dilating pupil;

          -  Any contraindication to cataract;

          -  Eyes with two different levels of cataract grade;

          -  Pregnant, or planned pregnancy during the study;

          -  Expected to require an ocular surgical treatment at any time during the study;

          -  Other protocol-specified exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alcon, A Novartis Division</last_name>
    <role>Study Director</role>
    <affiliation>Alcon, A Novartis Division</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alcon Call Center</last_name>
    <phone>1-888-451-3937</phone>
    <email>alcon.medinfo@alcon.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Contact Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2018</study_first_submitted>
  <study_first_submitted_qc>March 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2018</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

